Considerations for the Correct Diagnosis of COPD and Its Management With Bronchodilators

Antonio R Anzueto, Marc Miravitlles

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

COPD is often misdiagnosed and inappropriately treated in many patients. COPD is a distinct disease from adult-onset asthma; however, some patients with COPD may present with several forms of airway disease described as asthma-COPD overlap (ACO). Bronchodilators and inhaled corticosteroids (ICS) both have a place in standard maintenance treatment of COPD and asthma; however, recommendations for use differ widely. In patients with COPD, long-acting bronchodilators are effective initial monotherapy treatment, whereas ICS monotherapy is recommended as initial treatment in patients with asthma. Clinicians need to be confident in their diagnosis to ensure that correct treatment is given because misguided treatment decisions can result in significantly increased safety risks for patients. This review highlights the differences in diagnosis and treatment between COPD, asthma, and ACO and discusses the data supporting guideline recommendations for use of bronchodilators in COPD treatment in contrast to asthma or ACO.

Original languageEnglish (US)
JournalChest
DOIs
StateAccepted/In press - Jan 1 2018
Externally publishedYes

Fingerprint

Bronchodilator Agents
Chronic Obstructive Pulmonary Disease
Asthma
Therapeutics
Adrenal Cortex Hormones
Patient Safety
Diagnostic Errors
Guidelines

Keywords

  • asthma-COPD overlap
  • bronchodilators
  • COPD
  • diagnosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Considerations for the Correct Diagnosis of COPD and Its Management With Bronchodilators. / Anzueto, Antonio R; Miravitlles, Marc.

In: Chest, 01.01.2018.

Research output: Contribution to journalArticle

@article{b861387714994d6abe86441919eb8e89,
title = "Considerations for the Correct Diagnosis of COPD and Its Management With Bronchodilators",
abstract = "COPD is often misdiagnosed and inappropriately treated in many patients. COPD is a distinct disease from adult-onset asthma; however, some patients with COPD may present with several forms of airway disease described as asthma-COPD overlap (ACO). Bronchodilators and inhaled corticosteroids (ICS) both have a place in standard maintenance treatment of COPD and asthma; however, recommendations for use differ widely. In patients with COPD, long-acting bronchodilators are effective initial monotherapy treatment, whereas ICS monotherapy is recommended as initial treatment in patients with asthma. Clinicians need to be confident in their diagnosis to ensure that correct treatment is given because misguided treatment decisions can result in significantly increased safety risks for patients. This review highlights the differences in diagnosis and treatment between COPD, asthma, and ACO and discusses the data supporting guideline recommendations for use of bronchodilators in COPD treatment in contrast to asthma or ACO.",
keywords = "asthma-COPD overlap, bronchodilators, COPD, diagnosis",
author = "Anzueto, {Antonio R} and Marc Miravitlles",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.chest.2018.02.023",
language = "English (US)",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",

}

TY - JOUR

T1 - Considerations for the Correct Diagnosis of COPD and Its Management With Bronchodilators

AU - Anzueto, Antonio R

AU - Miravitlles, Marc

PY - 2018/1/1

Y1 - 2018/1/1

N2 - COPD is often misdiagnosed and inappropriately treated in many patients. COPD is a distinct disease from adult-onset asthma; however, some patients with COPD may present with several forms of airway disease described as asthma-COPD overlap (ACO). Bronchodilators and inhaled corticosteroids (ICS) both have a place in standard maintenance treatment of COPD and asthma; however, recommendations for use differ widely. In patients with COPD, long-acting bronchodilators are effective initial monotherapy treatment, whereas ICS monotherapy is recommended as initial treatment in patients with asthma. Clinicians need to be confident in their diagnosis to ensure that correct treatment is given because misguided treatment decisions can result in significantly increased safety risks for patients. This review highlights the differences in diagnosis and treatment between COPD, asthma, and ACO and discusses the data supporting guideline recommendations for use of bronchodilators in COPD treatment in contrast to asthma or ACO.

AB - COPD is often misdiagnosed and inappropriately treated in many patients. COPD is a distinct disease from adult-onset asthma; however, some patients with COPD may present with several forms of airway disease described as asthma-COPD overlap (ACO). Bronchodilators and inhaled corticosteroids (ICS) both have a place in standard maintenance treatment of COPD and asthma; however, recommendations for use differ widely. In patients with COPD, long-acting bronchodilators are effective initial monotherapy treatment, whereas ICS monotherapy is recommended as initial treatment in patients with asthma. Clinicians need to be confident in their diagnosis to ensure that correct treatment is given because misguided treatment decisions can result in significantly increased safety risks for patients. This review highlights the differences in diagnosis and treatment between COPD, asthma, and ACO and discusses the data supporting guideline recommendations for use of bronchodilators in COPD treatment in contrast to asthma or ACO.

KW - asthma-COPD overlap

KW - bronchodilators

KW - COPD

KW - diagnosis

UR - http://www.scopus.com/inward/record.url?scp=85048546920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048546920&partnerID=8YFLogxK

U2 - 10.1016/j.chest.2018.02.023

DO - 10.1016/j.chest.2018.02.023

M3 - Article

JO - Chest

JF - Chest

SN - 0012-3692

ER -